D-0597-2025 Class II Ongoing
FDA drug recall D-0597-2025 was initiated by Cardinal Health Inc. on Aug 5, 2025 and is designated Class II. Reason for recall: Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL The recall status is ongoing. Affected quantity: 10 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 3, 2025
- Initiation Date
- Aug 5, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10 bags
Product description
Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01
Reason for recall
Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL
Distribution pattern
KS
Code information
Outer package - NDC 55154-3543-5, Lot SAD08033AA Inner label - NDC 0781-3238-01, Lot SAF13211A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0597-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026